Choosing Between Tesofensine and MK-677: A 2026 Decision Guide

Tesofensine at a glance:

• Drug class: Growth hormone secretagogue
• Route: subcutaneous injection (peptides) or oral (small molecules)
• Typical frequency: once daily to once weekly depending on agent
• Half-life: varies (minutes for sermorelin; days for CJC-1295 DAC; hours for MK-677)

If you're choosing between two specific options, the right framework is rarely "which is better in general" — it's "which is better for me, given my insurance, side-effect tolerance, and dosing preference." We try to make that comparison honest below.

Mechanism

Tesofensine: Growth hormone secretagogues stimulate endogenous GH release through either the GHRH receptor (GHRH analogs) or the GHS-R1a/ghrelin receptor (ghrelin mimetics).

MK-677: MK-677 is a small-molecule, orally active ghrelin receptor agonist that increases GH and IGF-1 levels by mimicking ghrelin's action on the pituitary.

For people new to this comparison, the practical takeaway is that the underlying mechanisms are different enough that response can vary.

Dosing & Administration

Effectiveness

Tesofensine: Increased GH and IGF-1 levels.

MK-677: Sustained increase in IGF-1 and GH levels; modest increases in lean mass and appetite.

In head-to-head comparisons (where they exist), the higher-dose newer agents tend to outperform older ones — sometimes meaningfully. Reference trials: Stanley 2010 (tesamorelin in HIV-lipodystrophy); Nass 2008 (MK-677 in older adults) for Tesofensine; Nass et al for MK-677.

Side Effects

The two compounds have overlapping side-effect profiles. Common to both:

• injection-site reactions
• fluid retention
• joint pain
• headache
• increased appetite
• edema

Important risks worth knowing for both:

• impaired glucose tolerance
• carpal tunnel syndrome
• theoretical IGF-1-mediated effects on tumor growth
• elevated cortisol in some studies

Cost

Tesofensine: pricing varies. MK-677: pricing varies.

Insurance coverage and manufacturer programs change the relative cost picture significantly. See our individual cost guides for Tesofensine cost and MK-677 cost for the latest numbers.

Which Is Right for You?

The practical decision usually comes down to four factors:

1. What's covered by your insurance? Often the deciding factor
2. What does your prescriber have experience with? Familiarity reduces dosing errors
3. How comfortable are you with injections (or oral dosing if applicable)?
4. What's your tolerance for side effects?

If you and your clinician end up split between Tesofensine and MK-677, either is a defensible choice in most cases.

Switching Between Them

Switching from Tesofensine to MK-677 (or the reverse) is usually straightforward but should be done with clinician guidance — particularly to align dose escalation and avoid GI side effects from re-titration.

Bottom Line

Both Tesofensine and its alternative are defensible choices. The right pick comes from your specific situation — insurance, prescriber, tolerance — not from the molecule alone.

Frequently Asked Questions

Related Reading

• The Honest Guide to Tesofensine: What Patients and Doctors Actually Say
• Tesofensine Side Effects: 7 Things to Watch For (and How to Manage Them)
• Tesofensine Outcomes Decoded: Who Responds Best and Why
• Why Tesofensine Costs So Much (and 5 Ways to Pay Less)
• The Honest Guide to MK-677: What Patients and Doctors Actually Say
• Is MK-677 Safe? An Honest Look at the Side-Effect Profile

Sources

• Stanley TL et al. Effects of Tesamorelin on Visceral Fat in HIV-Infected Patients With Lipodystrophy. NEJM 2010;363:2425.
• Nass R et al. Effects of an Oral Ghrelin Mimetic on Body Composition in Healthy Older Adults. Annals of Internal Medicine 2008;149:601.
• Teichman SL et al. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295. JCEM 2006;91:799.

This page is informational only and is not a personalized recommendation. The right choice depends on your individual situation.